BlackRock International V.I. Fund Q4 2024 Commentary
Source: SeekingAlpha
2025-03-20 21:55:00 ET
Summary
- BlackRock International V.I. Fund posted a return of -4.75% (Class I shares) for the fourth quarter of 2024.
- The top contributors were Sony, Marvell, and Recruit.
- Novo Nordisk performed weakly due to disappointing Phase 3 results for key anti-obesity drug candidate Cagrisema.
Average annual total returns (%) as of 12/31/24
4Q24 (not annualized) | YTD (not annualized) | 1 Year | 3 Year | 5 Years | 10 Years | |
Class I (Without Sales Charge) 1 | -4.75 | 0.37 | 0.37 | -3.43 | 3.49 | 4.61 |
MSCI EAFE 2 | -8.11 | 3.82 | 3.82 | 1.65 | 4.73 | 5.20 |
Read the full article on Seeking Alpha
For further details see:
BlackRock International V.I. Fund Q4 2024 Commentary
Recruit Holdings Co Ltd
NASDAQ: RCRRF
RCRRF Trading
-0.5% G/L:
$39.26 Last:
801 Volume:
$39.26 Open:
